Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › KY › Corbin › NPI 1902865389
Clinic

Baptist Healthcare System, INC

Baptist Healthcare System, INC was paid $121.50M by Medicaid between Jan 2018 and Dec 2024, across 497 billing codes. Its largest line is 99283, emergency room visit (moderate) — 8.8% of everything it billed.

33Billing provider infoBAPTIST HEALTHCARE SYSTEM, INC
CORBIN, KY 40701
33aNPI1902865389assigned 03/22/2006
33bProvider typeOccupational Medicine Clinic/Center
28Total paid$121.50M
24GClaims2,489,029
24DCodes billed497
24AFirst – last monthJan 2018 – Dec 2024

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official CARRICO, RICHARD controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$1.0M$2.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018335,917$16.59M
2019320,024$16.47M
2020323,465$15.74M
2021394,821$18.72M
2022388,649$17.80M
2023395,002$18.90M
2024incomplete331,151$17.28M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 8.8% 74,797 65,204 $10.63M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 8.4% 46,203 38,769 $10.19M
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 6.4% 24,318 9,229 $7.72M
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 5.9% 19,006 17,212 $7.20M
0202U Oncology (prostate), multianalyte, gene expression profiling 4.0% 15,837 14,771 $4.85M
74177 Computed tomography, abdomen and pelvis; with contrast material 3.6% 12,600 11,025 $4.40M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 3.5% 15,011 11,276 $4.30M
74176 Computed tomography, abdomen and pelvis; without contrast material 3.1% 12,558 11,022 $3.73M
93017 2.3% 10,734 10,032 $2.76M
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 2.1% 33,852 14,615 $2.52M
70450 Computed tomography, head or brain; without contrast material 2.0% 14,816 12,113 $2.40M
47562 1.7% 1,929 1,391 $2.10M
485 more codes
G0378 Hospital observation service, per hour 1.3% 4,115 $1.62M
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 1.2% 21,795 $1.50M
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 1.2% 5,969 $1.46M
80053 Comprehensive metabolic panel 1.1% 183,546 $1.37M
96375 Therapeutic injection; each additional sequential IV push <1% 29,412 $1.18M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 22,709 $1.14M
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 36,997 $1.03M
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 3,499 $945K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 34,491 $943K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 52,683 $929K
71275 Computed tomographic angiography, chest, with contrast material <1% 4,515 $920K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 6,828 $890K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 9,336 $883K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 123,555 $843K
J0875 Injection, dalbavancin, 5 mg <1% 488 $806K
59025 Fetal non-stress test <1% 8,869 $796K
74178 <1% 1,595 $796K
J2785 Injection, regadenoson, 0.1 mg <1% 5,020 $780K
71045 Radiologic examination, chest; single view <1% 29,583 $778K
72125 Computed tomography, cervical spine; without contrast material <1% 4,583 $737K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r <1% 11,922 $735K
36415 Collection of venous blood by venipuncture <1% 187,473 $716K
96361 Intravenous infusion, hydration; each additional hour <1% 14,475 $702K
72110 <1% 5,411 $702K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 3,113 $699K
74018 <1% 10,937 $661K
72131 <1% 3,834 $648K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 4,125 $624K
77067 Screening mammography, bilateral, including computer-aided detection <1% 8,138 $618K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 7,424 $587K
71250 <1% 5,441 $573K
71046 Radiologic examination, chest; 2 views <1% 18,518 $526K
93971 <1% 3,378 $518K
H0015 Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education <1% 3,734 $509K
80050 General health panel <1% 14,348 $497K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 5,889 $473K
96367 <1% 6,754 $452K
0099U <1% 1,904 $449K
73630 <1% 5,574 $449K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 5,403 $445K
73562 <1% 5,669 $431K
73030 <1% 6,466 $422K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 2,579 $410K
70551 Magnetic resonance imaging, brain; without contrast material <1% 1,919 $407K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 1,134 $405K
J9271 Injection, pembrolizumab, 1 mg <1% 86 $402K
73610 <1% 5,259 $401K
42820 Tonsillectomy and adenoidectomy; younger than age 12 <1% 373 $371K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 4,655 $366K
70486 <1% 1,899 $365K
93880 <1% 2,715 $364K
72050 <1% 3,414 $349K
73130 <1% 4,441 $347K
84484 <1% 35,061 $342K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 1,337 $330K
72128 <1% 2,159 $327K
S9480 Intensive outpatient psychiatric services, per diem <1% 2,421 $326K
76775 <1% 2,686 $324K
83880 <1% 10,775 $321K
73110 <1% 3,871 $315K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 5,846 $309K
72141 <1% 1,407 $306K
80061 Lipid panel <1% 25,075 $304K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 12,322 $300K
93970 <1% 1,581 $299K
84443 Thyroid stimulating hormone (TSH) <1% 20,626 $291K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 1,149 $290K
76642 <1% 3,078 $276K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 9,529 $264K
78815 Positron emission tomography (PET) for limited area imaging <1% 643 $260K
96376 <1% 6,689 $256K
76536 <1% 3,154 $253K
58571 <1% 268 $250K
82805 <1% 5,882 $247K
77066 Tomosynthesis, mammo <1% 3,578 $233K
87040 <1% 26,903 $219K
50590 <1% 276 $214K
73564 <1% 1,774 $209K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 25,683 $208K
H0035 Mental health partial hospitalization, treatment, less than 24 hours <1% 1,084 $206K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 690 $199K
74022 <1% 1,897 $195K
87507 <1% 740 $193K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 4,173 $191K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 379 $183K
72072 <1% 2,080 $182K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 12,753 $172K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 2,276 $171K
80074 <1% 4,414 $171K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 600 $169K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 7,148 $168K
78227 <1% 531 $168K
10060 <1% 596 $167K
83735 <1% 26,281 $163K
82607 <1% 13,077 $159K
87086 Culture, bacterial; quantitative colony count, urine <1% 22,000 $153K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 23,021 $151K
83605 <1% 17,665 $147K
0097U <1% 617 $147K
93225 <1% 1,977 $147K
94060 <1% 2,075 $143K
83036 Hemoglobin; glycosylated (A1C) <1% 17,547 $142K
73090 <1% 2,050 $142K
93226 <1% 1,118 $139K
73502 <1% 2,949 $137K
83690 <1% 24,507 $137K
73080 <1% 2,013 $136K
78226 <1% 520 $134K
80048 Basic metabolic panel (calcium, ionized) <1% 22,376 $134K
96368 <1% 1,561 $132K
86140 <1% 34,612 $130K
77065 Tomosynthesis, mammo <1% 2,423 $130K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 2,438 $128K
82077 <1% 9,149 $128K
72100 <1% 1,953 $127K
73590 <1% 1,991 $125K
74240 <1% 586 $125K
73221 <1% 527 $123K
76830 Ultrasound, transvaginal <1% 1,442 $119K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 1,513 $118K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 9,801 $117K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 2,015 $117K
76870 <1% 1,501 $116K
97602 <1% 3,612 $116K
77080 <1% 3,481 $115K
84439 <1% 13,970 $113K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries <1% 787 $107K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 560 $107K
81001 <1% 39,863 $107K
87522 Neg quan hep c or qual rna <1% 2,778 $101K
84112 <1% 1,144 $99K
80306 <1% 6,655 $99K
J7050 Infusion, normal saline solution, 250 cc <1% 3,276 $99K
81025 <1% 19,979 $98K
A9577 Injection, gadobenate dimeglumine (multihance), per ml <1% 1,860 $97K
82728 <1% 9,405 $97K
72040 <1% 1,154 $95K
87081 <1% 13,110 $91K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 157 $90K
12001 <1% 1,179 $90K
C1769 Guide wire <1% 1,087 $90K
70491 <1% 542 $88K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 329 $88K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 2,802 $86K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed <1% 447 $83K
87902 <1% 406 $83K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 2,747 $82K
87150 <1% 364 $79K
0002A <1% 3,750 $77K
96415 <1% 493 $77K
36600 <1% 5,027 $75K
84466 <1% 6,615 $75K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 2,216 $74K
85027 <1% 12,958 $74K
84703 <1% 10,619 $72K
71271 <1% 1,424 $72K
0001A <1% 4,028 $68K
58661 <1% 68 $68K
84403 <1% 2,884 $66K
70498 <1% 431 $66K
C1889 Implantable/insertable device, not otherwise classified <1% 991 $66K
84145 <1% 3,484 $65K
84702 <1% 4,517 $65K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 1,112 $65K
J2704 Injection, propofol, 10 mg <1% 18,762 $64K
85379 <1% 7,185 $63K
A9537 Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries <1% 1,274 $63K
85610 <1% 19,889 $63K
86003 <1% 935 $62K
J2505 Injection, pegfilgrastim, 6 mg <1% 16 $60K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 1,615 $60K
86850 <1% 6,790 $60K
94726 <1% 2,213 $59K
81003 <1% 27,386 $59K
70496 <1% 356 $57K
71101 <1% 820 $56K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 926 $56K
82375 <1% 5,624 $55K
90715 <1% 2,151 $55K
87186 <1% 7,081 $54K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 672 $54K
84153 <1% 4,574 $53K
85730 <1% 9,548 $52K
95819 <1% 195 $51K
94729 <1% 1,442 $47K
96417 <1% 391 $47K
83540 <1% 7,895 $46K
J2469 Injection, palonosetron hcl, 25 mcg <1% 1,121 $46K
93925 <1% 453 $46K
77336 <1% 482 $45K
77063 Screening digital breast tomosynthesis, bilateral <1% 11,078 $44K
64488 <1% 101 $44K
75574 <1% 174 $43K
12002 <1% 470 $42K
82746 <1% 3,395 $42K
82150 <1% 7,451 $42K
82670 <1% 2,442 $41K
G0432 Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening <1% 3,822 $40K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 2,694 $39K
J7030 Infusion, normal saline solution , 1000 cc <1% 9,114 $39K
76819 Fetal biophysical profile; without non-stress testing <1% 507 $37K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 20,788 $36K
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care <1% 1,774 $35K
82550 <1% 5,946 $35K
0100U <1% 71 $35K
87077 <1% 4,861 $33K
85652 <1% 15,032 $33K
82962 <1% 10,288 $31K
74019 <1% 483 $31K
74220 <1% 278 $31K
J2805 Injection, sincalide, 5 micrograms <1% 281 $31K
73060 <1% 489 $30K
87070 <1% 5,259 $30K
86803 <1% 2,309 $30K
83050 <1% 5,343 $30K
81596 <1% 493 $29K
76801 <1% 425 $29K
73523 <1% 223 $28K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 11,157 $28K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 2,407 $27K
87807 <1% 1,808 $26K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 22,469 $26K
82105 <1% 1,408 $26K
87147 <1% 3,384 $26K
G0297 Low dose ct scan (ldct) for lung cancer screening <1% 480 $25K
73560 <1% 333 $24K
80143 <1% 1,472 $24K
86038 <1% 2,243 $24K
P9612 Catheterization for collection of specimen, single patient, all places of service <1% 5,687 $23K
19081 <1% 32 $23K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 5,548 $23K
86901 <1% 6,865 $23K
86900 <1% 6,998 $23K
M0245 Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring <1% 107 $23K
82043 <1% 4,388 $23K
92526 <1% 459 $23K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 2,656 $22K
73552 <1% 403 $22K
87493 <1% 827 $22K
73700 <1% 85 $22K
76882 <1% 240 $22K
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 4,825 $21K
86677 <1% 762 $21K
J1170 Injection, hydromorphone, up to 4 mg <1% 7,938 $21K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 31,460 $20K
94727 <1% 496 $20K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 868 $20K
84481 <1% 1,350 $19K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 4,378 $19K
82784 <1% 2,020 $19K
80179 <1% 1,404 $18K
J0694 Injection, cefoxitin sodium, 1 gm <1% 1,702 $18K
83615 <1% 3,327 $17K
12011 <1% 189 $17K
83516 <1% 1,031 $17K
J0780 Injection, prochlorperazine, up to 10 mg <1% 3,654 $17K
78264 <1% 55 $17K
Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose <1% 9,095 $16K
36430 <1% 77 $16K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 13,335 $16K
J3370 Injection, vancomycin hcl, 500 mg <1% 2,401 $16K
73140 <1% 245 $16K
83655 <1% 1,327 $16K
82948 <1% 3,316 $16K
J2270 Injection, morphine sulfate, up to 10 mg <1% 7,978 $15K
72146 <1% 61 $15K
J7120 Ringers lactate infusion, up to 1000 cc <1% 3,034 $15K
87205 <1% 3,821 $15K
84550 <1% 3,507 $15K
C1751 Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) <1% 253 $14K
72081 <1% 80 $14K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 314 $14K
84100 <1% 3,491 $14K
J1756 Injection, iron sucrose, 1 mg <1% 231 $13K
86706 <1% 1,450 $13K
82570 <1% 2,914 $13K
82553 <1% 1,235 $12K
92609 <1% 167 $12K
83993 <1% 648 $11K
86364 <1% 1,027 $11K
97016 <1% 1,002 $11K
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 2,649 $11K
93308 <1% 78 $11K
84134 <1% 885 $11K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 600 $11K
82785 <1% 587 $11K
86704 <1% 1,044 $11K
97035 <1% 385 $10K
92523 <1% 126 $10K
93798 <1% 726 $10K
97162 <1% 227 $10K
93325 <1% 110 $10K
86708 <1% 951 $10K
82140 <1% 971 $9K
77300 <1% 51 $9K
J1453 Injection, fosaprepitant, 1 mg <1% 94 $9K
J3475 Injection, magnesium sulfate, per 500 mg <1% 1,512 $9K
82248 <1% 1,917 $9K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 14,471 $9K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 110 $9K
93320 <1% 68 $9K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 382 $9K
A4648 Tissue marker, implantable, any type, each <1% 96 $8K
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 1,583 $8K
36416 <1% 4,509 $8K
J0592 Injection, buprenorphine hydrochloride, 0.1 mg <1% 995 $8K
86308 <1% 1,712 $8K
76506 <1% 95 $8K
93356 <1% 412 $8K
84156 <1% 2,313 $8K
84402 <1% 384 $8K
Q9968 Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg <1% 117 $8K
86231 <1% 796 $8K
87899 <1% 441 $8K
87340 <1% 953 $8K
87088 <1% 1,101 $8K
84436 <1% 1,252 $7K
83550 <1% 795 $7K
J1644 Injection, heparin sodium, per 1000 units <1% 2,956 $7K
93923 <1% 117 $7K
29125 <1% 111 $7K
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 1,302 $7K
86376 <1% 553 $7K
P9016 Red blood cells, leukocytes reduced, each unit <1% 90 $7K
99195 <1% 213 $7K
86431 <1% 1,379 $7K
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 2,387 $7K
J1040 Injection, methylprednisolone acetate, 80 mg <1% 412 $7K
87631 <1% 42 $7K
93922 <1% 121 $7K
82247 <1% 1,390 $7K
J1650 Injection, enoxaparin sodium, 10 mg <1% 1,350 $6K
82977 <1% 966 $6K
J3490 Unclassified drugs <1% 91 $6K
97163 <1% 167 $6K
36591 <1% 460 $6K
83010 <1% 563 $6K
83874 <1% 473 $6K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 208 $6K
87046 <1% 442 $6K
J1580 Injection, garamycin, gentamicin, up to 80 mg <1% 2,384 $6K
96411 <1% 50 $6K
80076 <1% 726 $6K
73120 <1% 87 $6K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 14 $6K
72220 <1% 100 $6K
J0500 Injection, dicyclomine hcl, up to 20 mg <1% 71 $5K
87209 <1% 274 $5K
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) <1% 30 $5K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 4,137 $5K
M0239 Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring <1% 43 $5K
74246 <1% 55 $5K
C1781 Mesh (implantable) <1% 15 $5K
72082 <1% 13 $5K
A9541 Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries <1% 45 $4K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 3,687 $4K
J0690 Injection, cefazolin sodium, 500 mg <1% 1,459 $4K
J0561 Injection, penicillin g benzathine, 100,000 units <1% 28 $4K
91035 <1% 16 $4K
0042T <1% 15 $4K
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 2,085 $4K
94010 <1% 93 $4K
84146 <1% 217 $3K
J2060 Injection, lorazepam, 2 mg <1% 2,656 $3K
43248 <1% 15 $3K
51702 <1% 45 $3K
78306 <1% 28 $3K
83883 <1% 213 $3K
M0247 Intravenous infusion, sotrovimab, includes infusion and post administration monitoring <1% 17 $3K
94761 <1% 429 $3K
87581 <1% 115 $3K
87486 <1% 115 $3K
74241 <1% 12 $3K
87045 <1% 355 $3K
82378 <1% 147 $3K
0004A <1% 216 $3K
87177 <1% 287 $3K
82172 <1% 140 $3K
82525 <1% 263 $3K
82009 <1% 707 $2K
86618 <1% 170 $2K
83525 <1% 237 $2K
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 369 $2K
J2550 Injection, promethazine hcl, up to 50 mg <1% 2,534 $2K
J3411 Injection, thiamine hcl, 100 mg <1% 503 $2K
J1030 Injection, methylprednisolone acetate, 40 mg <1% 460 $2K
96523 <1% 312 $2K
76885 <1% 24 $2K
J2175 Injection, meperidine hydrochloride, per 100 mg <1% 630 $2K
72170 <1% 46 $2K
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg <1% 136 $2K
83970 <1% 67 $2K
86258 <1% 125 $2K
80202 <1% 138 $2K
C1726 Catheter, balloon dilatation, non-vascular <1% 13 $2K
83001 <1% 128 $2K
81050 <1% 547 $2K
86008 <1% 219 $2K
86800 <1% 134 $2K
86757 <1% 31 $2K
84132 <1% 505 $2K
J0595 Injection, butorphanol tartrate, 1 mg <1% 416 $2K
82270 <1% 404 $2K
83002 <1% 112 $2K
82652 <1% 40 $2K
94664 <1% 82 $2K
J0360 Injection, hydralazine hcl, up to 20 mg <1% 389 $2K
73000 <1% 18 $1K
84479 <1% 268 $1K
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 664 $1K
80164 <1% 162 $1K
82653 <1% 27 $1K
85014 <1% 310 $1K
81206 <1% 15 $1K
73070 <1% 13 $1K
J1790 Injection, droperidol, up to 5 mg <1% 322 $1K
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg <1% 261 $1K
J1596 Injection, glycopyrrolate, 0.1 mg <1% 504 $1K
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 92 $1K
82103 <1% 87 $1K
83921 <1% 63 $1K
81207 <1% 15 $1K
83631 <1% 56 $1K
73503 <1% 14 $1K
93246 <1% 27 $992.63
84630 <1% 77 $977.28
86592 <1% 283 $974.79
85045 <1% 256 $934.79
86666 <1% 28 $869.92
83520 <1% 40 $862.72
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 984 $850.63
86255 <1% 56 $821.65
85049 <1% 61 $796.38
93242 <1% 24 $727.68
74230 <1% 23 $714.04
0003A <1% 59 $679.20
82533 <1% 44 $657.72
86200 <1% 58 $654.60
82272 <1% 261 $648.99
86769 <1% 17 $639.26
97535 Self-care/home management training, each 15 minutes <1% 43 $628.22
94760 <1% 83 $588.10
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 91 $579.60
84460 <1% 118 $570.44
84144 <1% 32 $557.09
85007 <1% 191 $525.52
J3480 Injection, potassium chloride, per 2 meq <1% 57 $515.90
97139 <1% 156 $493.57
87484 <1% 23 $458.12
83630 <1% 28 $450.08
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 43 $445.86
82104 <1% 31 $433.80
84478 <1% 95 $431.43
87468 <1% 23 $382.71
86753 <1% 17 $327.75
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 15 $324.70
86015 <1% 25 $289.20
J1940 Injection, furosemide, up to 20 mg <1% 128 $289.04
87210 <1% 57 $277.87
82390 <1% 24 $277.26
84480 <1% 35 $273.48
86381 <1% 12 $249.41
86668 <1% 14 $237.38
J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm <1% 110 $236.49
87220 <1% 45 $229.13
J1171 Injection, hydromorphone, 0.1 mg <1% 127 $208.12
85018 <1% 103 $192.95
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 301 $191.29
90686 <1% 17 $183.97
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 13 $173.20
Q3014 Telehealth originating site facility fee <1% 33 $163.76
G0008 Administration of influenza virus vaccine <1% 17 $151.91
76999 <1% 32 $146.22
J3105 Injection, terbutaline sulfate, up to 1 mg <1% 120 $146.20
86141 <1% 12 $142.45
82330 <1% 13 $136.80
82465 <1% 30 $117.54
J1953 Injection, levetiracetam, 10 mg <1% 12 $103.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 158 $99.26
85384 <1% 12 $98.17
80178 <1% 14 $86.98
J7121 5% dextrose in lactated ringers infusion, up to 1000 cc <1% 14 $81.41
85651 <1% 18 $57.58
82947 <1% 12 $12.26
99499 0% 106 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCARRICO, RICHARD (CHIEF FINANCIAL OFFICER)
Same official

Other billing entities under CARRICO, RICHARD

Full network →
ProviderLocationPaid
Baptist Healthcare System, INCLexington, KY$98.07M
Baptist Healthcare System INCElizabethtown, KY$95.61M
Baptist Health Deaconess Madisonville INCMadisonville, KY$80.89M
Baptist Healthcare System, INCPaducah, KY$72.57M
Baptist Healthcare System INC.Louisville, KY$62.41M
Baptist Healthcare System, INC.Richmond, KY$58.51M
Baptist Healthcare System, INC.New Albany, IN$34.67M
Baptist Healthcare System, INC.La Grange, KY$16.01M
Baptist Health Surgery Center LLCLexington, KY$2.90M
Baptist Healthcare System, INC.Louisville, KY$1.34M
Baptist Healthcare System, INC.Lexington, KY$1.08M
Baptist Health Deaconess Madisonville INCMadisonville, KY$834K
Baptist Healthcare System, INC.Louisville, KY$184K
Baptist Healthcare System INCCorbin, KY$142K
Baptist Healthcare System INCNew Albany, IN$97K
Baptist Health Deaconess Madisonville INCMadisonville, KY$94K
Baptist Healthcare System INCElizabethtown, KY$54K
Baptist Healthcare System INCLouisville, KY$47K
Baptist Healthcare System INCLexington, KY$43K
Baptist Healthcare System, INC.Lexington, KY$10K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.